GlassScriptPhysician profile
Traci Bourgeois
NPI 1922502772
$406.93
in general payments reported to CMS, 2019-2025
12 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.75 · 2021: $28.23 · 2023: $81.61 · 2024: $69.73 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $137.03 | 2025 | Ozempic |
| Abbvie INC. | $54.29 | 2023-2024 | Vraylar |
| Otsuka America Pharmaceutical, INC. | $37.49 | 2023-2025 | Rexulti, Nuedexta |
| Novartis Pharmaceuticals Corporation | $28.42 | 2021-2025 | |
| Exact Sciences Corporation | $28.10 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $22.75 | 2019 | |
| Vanda Pharmaceuticals INC. | $20.28 | 2024 | Fanapt |
| Organon LLC | $19.94 | 2023 | Nexplanon |
| Xeris Pharmaceuticals, INC. | $15.34 | 2025 | Gvoke Hypopen |
| Janssen Pharmaceuticals, INC | $14.84 | 2023 | Spravato |
| Global Blood Therapeutics, INC. | $14.84 | 2021 | |
| Supernus Pharmaceuticals, INC. | $13.61 | 2023 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traci Bourgeois listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.